178 related articles for article (PubMed ID: 28977734)
1. Biosynthesis of the Enterotoxic Pyrrolobenzodiazepine Natural Product Tilivalline.
Dornisch E; Pletz J; Glabonjat RA; Martin F; Lembacher-Fadum C; Neger M; Högenauer C; Francesconi K; Kroutil W; Zangger K; Breinbauer R; Zechner EL
Angew Chem Int Ed Engl; 2017 Nov; 56(46):14753-14757. PubMed ID: 28977734
[TBL] [Abstract][Full Text] [Related]
2. Bacterial Indole as a Multifunctional Regulator of Klebsiella oxytoca Complex Enterotoxicity.
Ledala N; Malik M; Rezaul K; Paveglio S; Provatas A; Kiel A; Caimano M; Zhou Y; Lindgren J; Krasulova K; Illes P; Dvořák Z; Kortagere S; Kienesberger S; Cosic A; Pöltl L; Zechner EL; Ghosh S; Mani S; Radolf JD; Matson AP
mBio; 2022 Feb; 13(1):e0375221. PubMed ID: 35073747
[TBL] [Abstract][Full Text] [Related]
3. Tilivalline- and Tilimycin-Independent Effects of
Hering NA; Fromm A; Bücker R; Gorkiewicz G; Zechner E; Högenauer C; Fromm M; Schulzke JD; Troeger H
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717457
[No Abstract] [Full Text] [Related]
4. Biosynthesis, Mechanism of Action, and Inhibition of the Enterotoxin Tilimycin Produced by the Opportunistic Pathogen
Alexander EM; Kreitler DF; Guidolin V; Hurben AK; Drake E; Villalta PW; Balbo S; Gulick AM; Aldrich CC
ACS Infect Dis; 2020 Jul; 6(7):1976-1997. PubMed ID: 32485104
[TBL] [Abstract][Full Text] [Related]
5.
Unterhauser K; Pöltl L; Schneditz G; Kienesberger S; Glabonjat RA; Kitsera M; Pletz J; Josa-Prado F; Dornisch E; Lembacher-Fadum C; Roier S; Gorkiewicz G; Lucena D; Barasoain I; Kroutil W; Wiedner M; Loizou JI; Breinbauer R; Díaz JF; Schild S; Högenauer C; Zechner EL
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3774-3783. PubMed ID: 30808763
[TBL] [Abstract][Full Text] [Related]
6. A tricyclic pyrrolobenzodiazepine produced by
Tse H; Gu Q; Sze KH; Chu IK; Kao RY; Lee KC; Lam CW; Yang D; Tai SS; Ke Y; Chan E; Chan WM; Dai J; Leung SP; Leung SY; Yuen KY
J Biol Chem; 2017 Nov; 292(47):19503-19520. PubMed ID: 28972161
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantification of enterotoxins tilimycin and tilivalline in biological matrices using HPLC high resolution ESMS
Glabonjat RA; Kitsera M; Unterhauser K; Lembacher-Fadum C; Högenauer C; Raber G; Breinbauer R; Zechner EL
Talanta; 2021 Jan; 222():121677. PubMed ID: 33167283
[TBL] [Abstract][Full Text] [Related]
8. The benzodiazepine-like natural product tilivalline is produced by the entomopathogenic bacterium Xenorhabdus eapokensis.
Wolff H; Bode HB
PLoS One; 2018; 13(3):e0194297. PubMed ID: 29596433
[TBL] [Abstract][Full Text] [Related]
9. Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis.
Schneditz G; Rentner J; Roier S; Pletz J; Herzog KA; Bücker R; Troeger H; Schild S; Weber H; Breinbauer R; Gorkiewicz G; Högenauer C; Zechner EL
Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13181-6. PubMed ID: 25157164
[TBL] [Abstract][Full Text] [Related]
10. Klebsiella oxytoca and Emerging Nosocomial Infections.
Neog N; Phukan U; Puzari M; Sharma M; Chetia P
Curr Microbiol; 2021 Apr; 78(4):1115-1123. PubMed ID: 33656584
[TBL] [Abstract][Full Text] [Related]
11. cAMP Receptor Protein Positively Regulates the Expression of Genes Involved in the Biosynthesis of
Rodríguez-Valverde D; León-Montes N; Soria-Bustos J; Martínez-Cruz J; González-Ugalde R; Rivera-Gutiérrez S; González-Y-Merchand JA; Rosales-Reyes R; García-Morales L; Hirakawa H; Fox JG; Girón JA; De la Cruz MA; Ares MA
Front Microbiol; 2021; 12():743594. PubMed ID: 34659176
[No Abstract] [Full Text] [Related]
12. Biosynthesis of the Klebsiella oxytoca Pathogenicity Factor Tilivalline: Heterologous Expression, in Vitro Biosynthesis, and Inhibitor Development.
von Tesmar A; Hoffmann M; Abou Fayad A; Hüttel S; Schmitt V; Herrmann J; Müller R
ACS Chem Biol; 2018 Mar; 13(3):812-819. PubMed ID: 29389112
[TBL] [Abstract][Full Text] [Related]
13. Klebsiella oxytoca inhibits Salmonella infection through multiple microbiota-context-dependent mechanisms.
Osbelt L; Almási ÉDH; Wende M; Kienesberger S; Voltz A; Lesker TR; Muthukumarasamy U; Knischewski N; Nordmann E; Bielecka AA; Giralt-Zúñiga M; Kaganovitch E; Kühne C; Baier C; Pietsch M; Müsken M; Greweling-Pils MC; Breinbauer R; Flieger A; Schlüter D; Müller R; Erhardt M; Zechner EL; Strowig T
Nat Microbiol; 2024 Jul; 9(7):1792-1811. PubMed ID: 38862602
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and pathogenic properties of Klebsiella oxytoca isolated from laboratory animals.
Darby A; Lertpiriyapong K; Sarkar U; Seneviratne U; Park DS; Gamazon ER; Batchelder C; Cheung C; Buckley EM; Taylor NS; Shen Z; Tannenbaum SR; Wishnok JS; Fox JG
PLoS One; 2014; 9(7):e100542. PubMed ID: 25057966
[TBL] [Abstract][Full Text] [Related]
15. Enterotoxin tilimycin from gut-resident Klebsiella promotes mutational evolution and antibiotic resistance in mice.
Kienesberger S; Cosic A; Kitsera M; Raffl S; Hiesinger M; Leitner E; Halwachs B; Gorkiewicz G; Glabonjat RA; Raber G; Lembacher-Fadum C; Breinbauer R; Schild S; Zechner EL
Nat Microbiol; 2022 Nov; 7(11):1834-1848. PubMed ID: 36289400
[TBL] [Abstract][Full Text] [Related]
16. Toxin-Producing Klebsiella oxytoca in Healthy Infants: Commensal or Pathobiont?
Greimel TM; Stampfer L; Leitner E; Kienesberger S; Zechner EL; Bozic M; Wagner GE; Unterhauser K; Kitsera M; Hauer AC; Gorkiewicz G; Wurm P; Valitutti F; Högenauer C; Hoffmann KM
J Pediatr Gastroenterol Nutr; 2022 Jan; 74(1):e1-e7. PubMed ID: 34520403
[TBL] [Abstract][Full Text] [Related]
17. Improved molecular characterization of the
Shibu P; McCuaig F; McCartney AL; Kujawska M; Hall LJ; Hoyles L
Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34142942
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis, synthesis, and biological activities of pyrrolobenzodiazepines.
Gerratana B
Med Res Rev; 2012 Mar; 32(2):254-93. PubMed ID: 20544978
[TBL] [Abstract][Full Text] [Related]
19. Identification of cytotoxin-producing Klebsiella oxytoca strains isolated from clinical samples with cell culture assays.
Validi M; Soltan-Dallal MM; Douraghi M; Fallah-Mehrabadi J; Rahimi-Foroushani A; Frohesh-Tehrani H
Microb Pathog; 2017 Dec; 113():1-4. PubMed ID: 28970173
[TBL] [Abstract][Full Text] [Related]
20. The Toxin-Producing Pathobiont Klebsiella oxytoca Is Not Associated with Flares of Inflammatory Bowel Diseases.
Zollner-Schwetz I; Herzog KA; Feierl G; Leitner E; Schneditz G; Sprenger H; Prattes J; Petritsch W; Wenzl H; Kump P; Gorkiewicz G; Zechner E; Högenauer C
Dig Dis Sci; 2015 Nov; 60(11):3393-8. PubMed ID: 26091802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
